Goodwill in USD of Endo International plc from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Endo International plc quarterly Goodwill history and change rate from Q4 2013 to Q4 2023.
  • Endo International plc Goodwill for the quarter ending 31 Dec 2023 was $1.35B, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Endo International plc Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.35B $0 0% 31 Dec 2023 10-K 06 Mar 2024
Q3 2023 $1.35B $0 0% 30 Sep 2023 10-Q 06 Nov 2023
Q2 2023 $1.35B -$97M -6.69% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $1.35B -$1.85B -57.7% 31 Mar 2023 10-Q 08 May 2023
Q4 2022 $1.35B -$1.85B -57.7% 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 $1.35B -$2.21B -62% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $1.45B -$2.11B -59.3% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $3.2B -$363M -10.2% 31 Mar 2022 10-Q 06 May 2022
Q4 2021 $3.2B -$363M -10.2% 31 Dec 2021 10-K 06 Mar 2024
Q3 2021 $3.56B $0 0% 30 Sep 2021 10-Q 05 Nov 2021
Q2 2021 $3.56B $0 0% 30 Jun 2021 10-Q 06 Aug 2021
Q1 2021 $3.56B $0 0% 31 Mar 2021 10-Q 07 May 2021
Q4 2020 $3.56B -$35.2M -0.98% 31 Dec 2020 10-K 06 Mar 2023
Q3 2020 $3.56B -$55.3M -1.53% 30 Sep 2020 10-Q 06 Nov 2020
Q2 2020 $3.56B -$55.7M -1.54% 30 Jun 2020 10-Q 06 Aug 2020
Q1 2020 $3.56B -$120M -3.26% 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $3.6B -$169M -4.5% 31 Dec 2019 10-K 01 Mar 2022
Q3 2019 $3.62B -$441M -10.9% 30 Sep 2019 10-Q 04 Nov 2019
Q2 2019 $3.62B -$439M -10.8% 30 Jun 2019 10-Q 05 Aug 2019
Q1 2019 $3.68B -$377M -9.29% 31 Mar 2019 10-Q 09 May 2019
Q4 2018 $3.76B -$685M -15.4% 31 Dec 2018 10-K 26 Feb 2021
Q3 2018 $4.06B -$394M -8.86% 30 Sep 2018 10-Q 08 Nov 2018
Q2 2018 $4.06B -$392M -8.82% 30 Jun 2018 10-Q 08 Aug 2018
Q1 2018 $4.06B -$593M -12.8% 31 Mar 2018 10-Q 08 May 2018
Q4 2017 $4.45B $0 0% 31 Dec 2017 10-K 28 Feb 2019
Q3 2017 $4.45B -$2.96B -39.9% 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 $4.45B -$2.97B -40% 30 Jun 2017 10-Q 08 Aug 2017
Q1 2017 $4.65B -$2.77B -37.4% 31 Mar 2017 10-Q 09 May 2017
Q4 2016 $4.45B -$2.85B -39% 31 Dec 2016 10-K 26 Feb 2020
Q3 2016 $7.41B +$744M +11.2% 30 Sep 2016 10-Q 08 Nov 2016
Q2 2016 $7.42B +$4.37B +144% 30 Jun 2016 10-Q 09 Aug 2016
Q1 2016 $7.42B +$4.4B +145% 31 Mar 2016 10-Q 06 May 2016
Q4 2015 $7.3B +$4.4B +152% 31 Dec 2015 8-K 08 May 2018
Q3 2015 $6.67B +$2.86B +75.2% 30 Sep 2015 10-Q 09 Nov 2015
Q2 2015 $3.04B -$489M -13.8% 30 Jun 2015 10-Q 10 Aug 2015
Q1 2015 $3.03B -$498M -14.1% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 $2.9B +$2.33B +412% 31 Dec 2014 10-K 01 Mar 2017
Q3 2014 $3.8B 30 Sep 2014 10-Q 10 Nov 2014
Q2 2014 $3.53B 30 Jun 2014 10-Q 04 Aug 2014
Q1 2014 $3.52B 31 Mar 2014 10-Q 09 May 2014
Q4 2013 $566M 31 Dec 2013 8-K 02 Jun 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.